Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;56(1):278-281.
doi: 10.1038/s41409-020-0989-z. Epub 2020 Jul 7.

Can we cure refractory Hodgkin's lymphoma with transplantation?

Stefan O Ciurea  1   2 , Piyanuch Kongtim  3 , Samer Srour  4 , Neeraj Saini  4 , Jin Im  4 , Jeremy Ramdial  4 , Issa Khouri  4 , Paolo Anderlini  4 , Uday Popat  4 , Chitra Hosing  4 , Richard E Champlin  4 , Hun J Lee  5 , Luis E Fayad  5 , Fredrick B Hagemeister  5 , Ana M Bica  6 , Lavinia Lipan  6 , Oana Craciun  6 , Cristina G Jercan  6 , Alina Tanase #  6   7 , Anca Colita #  6   8
Affiliations

Can we cure refractory Hodgkin's lymphoma with transplantation?

Stefan O Ciurea et al. Bone Marrow Transplant. 2021 Jan.
No abstract available

PubMed Disclaimer

References

    1. Martinez C, Gayoso J, Canals C, Finel H, Peggs K, Dominietto A, et al. Post-transplantation cyclophosphamide-based haploidentical transplantation as alternative to matched sibling or unrelated donor transplantation for Hodgkin lymphoma: a registry study of the lymphoma working party of the European society for blood and marrow transplantation. J Clin Oncol: Off J Am Soc Clin Oncol. 2017;35:3425–32. https://doi.org/10.1200/jco.2017.72.6869 . - DOI
    1. Lacerda MP, Arrais Rodrigues C, Pereira AD, Novis Y, Fonseca M, Silva RL, et al. Human leukocyte antigen-haploidentical transplantation for relapsed/refractory Hodgkin lymphoma: a multicenter analysis. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant. 2017;23:705–7. https://doi.org/10.1016/j.bbmt.2017.01.079 . - DOI
    1. Gauthier J, Castagna L, Garnier F, Guillaume T, Socie G, Maury S, et al. Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy. Bone marrow Transplant. 2017;52:689–96. https://doi.org/10.1038/bmt.2016.349 . - DOI - PubMed
    1. Castagna L, Bramanti S, Devillier R, Sarina B, Crocchiolo R, Furst S, et al. Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma. Bone marrow Transplant. 2017;52:797 https://doi.org/10.1038/bmt.2017.26 . - DOI - PubMed
    1. Marani C, Raiola AM, Morbelli S, Dominietto A, Ferrarazzo G, Avenoso D, et al. Haploidentical transplants with post-transplant cyclophosphamide for relapsed or refractory Hodgkin lymphoma: the role of comorbidity index and pretransplant positron emission tomography. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant. 2018;24:2501–8. https://doi.org/10.1016/j.bbmt.2018.07.025 . - DOI

MeSH terms

LinkOut - more resources